Midomafetamine Hydrochloride for stress disorders, post-traumatic

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 2 trial. Mid-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 24 Dec 2025: Trial started, NCT07469098
  2. 13 Mar 2026: Trial registered, NCT07469098

The trials

NCT07469098: Group vs Individual MDMA-Assisted Therapy for PTSD After the October 7, 2023 Events

State
Under way
Phase
Phase 2
People
168 planned
Started
24 Dec 2025
Primary completion
31 Dec 2028
Arms
Group-based MDMA-assisted therapy, Individual MDMA-assisted therapy
Results
None posted
  1. 24 Dec 2025: Trial started
  2. 13 Mar 2026: Trial registered

How the status changed

  1. 19 Nov 2026: First set: Phase 2 trial

About the treatment

Kind of treatment: Drug.

Also known as MDMA HCl.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.